Search
Advanced Search
LATEST NEWS
New Guidelines Recommend Women Wait Until 21 for Cervical Cancer Screening
South Korea not to renegotiate FTA with America
“New Moon” Takes Center Stage, Should Post Big Opening Weekend
Senate Democrats Fault GOP For Failing To Advance Alternative Health Reforms
JM Smucker Q2 profit more than doubles on Folgers acquisition
Ann Taylor turns to profit in Q3 on strong margins
Valero Energy to Permanently Shutter Delaware City Refinery
Wall Street Closes Lower For The Day, Mixed For The Week
EU signs $1 billion deal with Nigeria to support peace, good governance, energy
European markets fall, led by banks, oils
News
Latest Headlines
Quick Facts
Breaking News
Top Stories
Feature Articles
Politics
US Policy
General
Commodities
Canadian
UK
Indian
Wallstreet Events
Industry News
Economics
US Economic News
European Economic News
Asian Economic News
All Economic News
Forex
FX Top Stories
Currency Alerts
Mkt Sensitive News
Politics
European Mkt Updates
Asian Mkt Updates
Treasury Mkt Updates
Entertainment
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
Movie Reviews
DVD Releases
Box Office
Slide Shows
Business News
Press Releases
Commentary/Analysis
Daily Market Analysis
US Market Updates
US Commentary
Asian Commentary
European Commentary
Canadian Commentary
Indian Commentary
Sector/Market Trends
Stock Alerts
Stocks To Watch
Long Term Stocks
Before the Bell
$5 and Under
After the Bell
Intraday Updates
IPOs
Hot Stocks
Earnings Calendars
Upcoming Earnings
Latest Earnings
Pos Pre Announcements
Neg Pre Announcements
Corporate Calendars
Stock Splits
Stock Buybacks
Dividends
Conference Calls
FDA Calendar
Board Meetings
Mergers & Acquisitions
Ratings Changes
Upgrades
Downgrades
Coverage Initiations
Coverage Reiterated
Video News
All Videos
Market Commentary
Top Stories
Economic News
Political News
Foreign Markets
Corporate News
Entertainment News
Audio News
Top Stories
Earnings
Mergers & Acquisitions
Market Commentary
Economic News
IPOs and New Issues
Corporate News
Forex News
Interviews
Private Equity
Economic Calendar
RTT DeskAlert
Bristol-Myers Squibb Co.(BMY)
RTTNews Articles
FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
11/20/2009 7:44:07 PM RTT News
Bristol-Myers Squibb Gets FDA Approval To Market Abilify For Treatment Of Irritability Associated With Autistic Disorder - Quick Facts
11/20/2009 6:58:14 PM RTT News
Bristol-Myers Squibb, Otsuka Pharma Reveal FDA Approves ABILIFY For Treatment Of Irritability Associated With Autistic Disorder
11/20/2009 6:51:52 PM RTT News
FDA Says Heartburn Drug Omeprazole Reduces Efficacy Of Blood Thinner Plavix - Update
11/17/2009 11:34:07 PM RTT News
Bristol-Myers Squibb Set New High For Year Monday
11/17/2009 8:49:14 AM RTT News
Bristol-Myers Squibb To Split-off Mead Johnson As Independent BioPharma Company - Update
11/15/2009 9:26:40 PM RTT News
Bristol-Myers Squibb To Split Off Stake In Mead Johnson Nutrition - Quick Facts
11/15/2009 7:23:18 PM RTT News
Bristol-Myers Squibb To Present At Credit Suisse Healthcare Conference; Webcast At 10:30 AM ET
11/12/2009 8:19:51 AM RTT News
Bristol-Myers Squibb To Present At Credit Suisse Healthcare Conference; Webcast At 10:30 AM ET
11/12/2009 6:44:00 AM RTT News
Bristol-Myers Squibb And Alder Announce Deal On ALD518 To Treat Rheumatoid Arthritis - Update
11/10/2009 8:59:44 AM RTT News
Previous 10 Headlines
Press Releases
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
11/20/2009 6:50:03 PM Business Wire
Critical Alerts for Chevron, Bristol-Myers Squibb, Gold Fields, Novellus, and Host Hotels Released by Seven Summits Research
11/20/2009 9:31:07 AM PR Newswire
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
11/15/2009 7:00:03 PM Business Wire
M3 USA and Bristol-Myers Squibb to Launch Next-Generation eMarketing Solution
11/13/2009 8:00:18 AM Business Wire
Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
11/10/2009 9:00:41 AM Business Wire
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
11/10/2009 7:00:16 AM Business Wire
BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB
11/6/2009 5:40:01 AM Market Wire
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
11/5/2009 6:09:03 PM Business Wire
BARACLUDE(R) (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
10/31/2009 5:31:02 PM Business Wire
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
10/31/2009 5:30:49 PM Business Wire
Previous10 Headlines
Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the
Terms of Service
.
Feedback
|
Terms of Service
|
How To Use RTTNews.com
|
Advertise
|
Buy Content
|
RSS